SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-103615
Filing Date
2023-04-17
Accepted
2023-04-17 16:01:59
Documents
7
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A d417293dpre14a.htm PRE 14A 324083
2 GRAPHIC g417293dsp001.jpg GRAPHIC 132062
3 GRAPHIC g417293dsp002.jpg GRAPHIC 87543
4 GRAPHIC g417293g28t44.jpg GRAPHIC 32634
5 GRAPHIC g417293g41j76.jpg GRAPHIC 24535
6 GRAPHIC g417293g65y00.jpg GRAPHIC 59419
7 GRAPHIC g417293g83w89.jpg GRAPHIC 25740
  Complete submission text file 0001193125-23-103615.txt   802045
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38938 | Film No.: 23823938
SIC: 2834 Pharmaceutical Preparations